Browsing by Author "Mohammed Rassool"
Now showing 1 - 5 of 5
- Results Per Page
- Sort Options
Item Bedaquilinepretomanidmoxifloxacinpyrazinamide for drugsensitive and drugresistant pulmonary tuberculosis treatment a phase 2c openlabel multicentre partially randomised controlled trial(ELSEVIER SCIENCE INC) Muge Cevik; Lindsay C Thompson; Caryn Upton; Valeria Cavalcanti Rolla; Mohammed Rassool; Francesca CONRADIEItem The lived experiences of tuberculosis survivors during the COVID19 pandemic and government lockdown in South Africa a qualitative analysis(BIOMED CENTRAL LTD) Ann Scheunemann; Aneesa Moolla; Constance Mongwenyana; Nelisiwe Mkize; Mohammed Rassool; Vuyokazi Jezile (CHRU Staff); Denise EvansItem Longterm efficacy and safety of two short standardised regimens for the treatment of rifampicinresistant tuberculosis STREAM stage 2 extended followup of an openlabel multicentre randomised noninferiority trial(ELSEVIER SCI LTD) R Goodall; A Nunn; S Meredith; A Bayissa; Mohammed Rassool; F Conradie; T Mwelase; E et alItem Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily With Emtricitabine and Tenofovir Disoproxil Fumarate for Previously Untreated HIV1 Infection Week 96 Results From ONCEMRK a Randomized DoubleBlind Noninferiority TrialPedro Cahn; Paul E Sax; Kathleen Squires; Jean-Michel Molina; Mohammed Rassool; E et alItem Short oral regimens for pulmonary rifampicinresistant tuberculosis TBPRACTECAL an openlabel randomised controlled phase 2B3 multiarm multicentre noninferiority trial(ELSEVIER SCI LTD) Bern-Thomas Nyang'wa; C Berry; Emil Kazounis; I Motta; Mohammed Rassool